TY - JOUR
T1 - Manejo clínico de la seudoobstrucción aguda de colon en el enfermo hospitalizado
T2 - Revisión sistemática de la bibliografía
AU - Delgado-Aros, S.
AU - Camilleri, M.
N1 - Funding Information:
El Dr. Camilleri ha recibido becas del NIH (R01-DK54681 y K24-DK02638). La Dra. Silvia Delgado-Aros ha recibido apoyo financiero en parte del Dr. Ralph and Marian C. Falk Medical Research Trust Fellowship for Clinical Research Training y de la Societat Catalana de Digestologia, como beneficiaria de la Beca de Formació de Llarga Durada a l’Estranger (2002-2003). Correspondencia: S. Delgado-Aros, MD, PhD. Mayo Clinic. Charlton, 8-110. 200 First Street S.W. Rochester, MN 55905. USA. Correo electrónico: delgado.silvia@mayo.edu
PY - 2003/12
Y1 - 2003/12
N2 - Intestinal pseudoobstruction is a clinical syndrome characterized by impairment of intestinal propulsion, which may resemble intestinal obstruction, in the absence of a mechanical cause. It usually affects the colon but the small intestine may also be involved, and may present in acute, subacute or chronic forms. We have performed a systematic review of the acute form of pseudoobstruction, also referred to as Ogilvie's syndrome. We discuss proposed pathophysiological mechanisms, manifestations and management of this clinical condition in post-surgery and critically ill patients. The hallmark of the syndrome is massive Intestinal distension, which is detected on clinical inspection and plain abdominal radiography. The underlying pathophysiological mechanisms are not fully understood. Therefore, treatment has focussed on preventing intestinal perforation, which is associated with a 21% mortality rate.
AB - Intestinal pseudoobstruction is a clinical syndrome characterized by impairment of intestinal propulsion, which may resemble intestinal obstruction, in the absence of a mechanical cause. It usually affects the colon but the small intestine may also be involved, and may present in acute, subacute or chronic forms. We have performed a systematic review of the acute form of pseudoobstruction, also referred to as Ogilvie's syndrome. We discuss proposed pathophysiological mechanisms, manifestations and management of this clinical condition in post-surgery and critically ill patients. The hallmark of the syndrome is massive Intestinal distension, which is detected on clinical inspection and plain abdominal radiography. The underlying pathophysiological mechanisms are not fully understood. Therefore, treatment has focussed on preventing intestinal perforation, which is associated with a 21% mortality rate.
UR - http://www.scopus.com/inward/record.url?scp=0345872465&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0345872465&partnerID=8YFLogxK
U2 - 10.1157/13055137
DO - 10.1157/13055137
M3 - Review article
C2 - 14670240
AN - SCOPUS:0345872465
SN - 0210-5705
VL - 26
SP - 646
EP - 655
JO - Gastroenterologia y Hepatologia
JF - Gastroenterologia y Hepatologia
IS - 10
ER -